Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Key Research Applications Tendon and connective tissue repair: The BPC-157 TB-500 blend provides both localized fibroblast stimulation via BPC-157 and systemic cell migration via TB-500, making it a powerful dual-pathway tool for tendon injury research
doi: 10.1038/nature23007 30 IshidaTTakahashiTKurokawaYNishidaTHirotaSSeradaSet al
A number of studies have shown that GLP-/GIPR dual agonists can achieve better blood glucose control, insulin sensitivity, lipid metabolism and weight loss compared with GLP-1 alone [136,137]
This effect contributes to a feeling of fullness that lasts longer, which can naturally lead to reduced food intake and, subsequently, weight loss
GLP-1 medications are not generally considered controlled substances under the Ryan Haight Act, so standard controlled substance telehealth prescribing restrictions don't apply
Bottom Line BPC-157 shows promising regenerative effects in animal models across multiple tissue types, and the small body of human pilot data is encouraging
US$ 24.19
US$ 23.08
)
US$ 22.42
US$ 22.40
)
US$ 24.53
